Incyte JAK Inhibitor Shows Promising One-Month Data In Rheumatoid Arthritis
Phase IIb RA studies launch later this year; myelofibrosis update set for December ASH meeting.
Phase IIb RA studies launch later this year; myelofibrosis update set for December ASH meeting.